BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 23257359)

  • 1. Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.
    Augello MA; Burd CJ; Birbe R; McNair C; Ertel A; Magee MS; Frigo DE; Wilder-Romans K; Shilkrut M; Han S; Jernigan DL; Dean JL; Fatatis A; McDonnell DP; Visakorpi T; Feng FY; Knudsen KE
    J Clin Invest; 2013 Jan; 123(1):493-508. PubMed ID: 23257359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation.
    Burd CJ; Petre CE; Morey LM; Wang Y; Revelo MP; Haiman CA; Lu S; Fenoglio-Preiser CM; Li J; Knudsen ES; Wong J; Knudsen KE
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2190-5. PubMed ID: 16461912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of ASF/SF2 as a critical, allele-specific effector of the cyclin D1b oncogene.
    Olshavsky NA; Comstock CE; Schiewer MJ; Augello MA; Hyslop T; Sette C; Zhang J; Parysek LM; Knudsen KE
    Cancer Res; 2010 May; 70(10):3975-84. PubMed ID: 20460515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1b splice variant promotes αvβ3-mediated adhesion and invasive migration of breast cancer cells.
    Wu FH; Luo LQ; Liu Y; Zhan QX; Luo C; Luo J; Zhang GM; Feng ZH
    Cancer Lett; 2014 Dec; 355(1):159-67. PubMed ID: 25193465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequence of the tumor-associated conversion to cyclin D1b.
    Augello MA; Berman-Booty LD; Carr R; Yoshida A; Dean JL; Schiewer MJ; Feng FY; Tomlins SA; Gao E; Koch WJ; Benovic JL; Diehl JA; Knudsen KE
    EMBO Mol Med; 2015 May; 7(5):628-47. PubMed ID: 25787974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 splice variants: polymorphism, risk, and isoform-specific regulation in prostate cancer.
    Comstock CE; Augello MA; Benito RP; Karch J; Tran TH; Utama FE; Tindall EA; Wang Y; Burd CJ; Groh EM; Hoang HN; Giles GG; Severi G; Hayes VM; Henderson BE; Le Marchand L; Kolonel LN; Haiman CA; Baffa R; Gomella LG; Knudsen ES; Rui H; Henshall SM; Sutherland RL; Knudsen KE
    Clin Cancer Res; 2009 Sep; 15(17):5338-49. PubMed ID: 19706803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing of the cyclin D1 proto-oncogene is regulated by the RNA-binding protein Sam68.
    Paronetto MP; Cappellari M; Busà R; Pedrotti S; Vitali R; Comstock C; Hyslop T; Knudsen KE; Sette C
    Cancer Res; 2010 Jan; 70(1):229-39. PubMed ID: 20028857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TMPRSS4 induces invasion and proliferation of prostate cancer cells through induction of Slug and cyclin D1.
    Lee Y; Ko D; Min HJ; Kim SB; Ahn HM; Lee Y; Kim S
    Oncotarget; 2016 Aug; 7(31):50315-50332. PubMed ID: 27385093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1b Splice Variant Promotes αvβ3-mediated EMT Induced by LPS in Breast Cancer Cells.
    Luo BP; Luo J; Hu YB; Yao XW; Wu FH
    Curr Med Sci; 2018 Jun; 38(3):467-472. PubMed ID: 30074214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin D1 is a selective modifier of androgen-dependent signaling and androgen receptor function.
    Comstock CES; Augello MA; Schiewer MJ; Karch J; Burd CJ; Ertel A; Knudsen ES; Jessen WJ; Aronow BJ; Knudsen KE
    J Biol Chem; 2011 Mar; 286(10):8117-8127. PubMed ID: 21212260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 repressor domain mediates proliferation and survival in prostate cancer.
    Schiewer MJ; Morey LM; Burd CJ; Liu Y; Merry DE; Ho SM; Knudsen KE
    Oncogene; 2009 Feb; 28(7):1016-27. PubMed ID: 19079343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin D1b variant promotes cell invasiveness independent of binding to CDK4 in human bladder cancer cells.
    Kim CJ; Nishi K; Isono T; Okuyama Y; Tambe Y; Okada Y; Inoue H
    Mol Carcinog; 2009 Oct; 48(10):953-64. PubMed ID: 19415719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1b induces changes in the macrophage phenotype resulting in promotion of tumor metastasis.
    Wang Y; Liu Y; Xiang L; Han L; Yao X; Hu Y; Wu F
    Exp Biol Med (Maywood); 2021 Dec; 246(24):2559-2569. PubMed ID: 34514884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer.
    Sanchez G; Bittencourt D; Laud K; Barbier J; Delattre O; Auboeuf D; Dutertre M
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6004-9. PubMed ID: 18413612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slug, a unique androgen-regulated transcription factor, coordinates androgen receptor to facilitate castration resistance in prostate cancer.
    Wu K; Gore C; Yang L; Fazli L; Gleave M; Pong RC; Xiao G; Zhang L; Yun EJ; Tseng SF; Kapur P; He D; Hsieh JT
    Mol Endocrinol; 2012 Sep; 26(9):1496-507. PubMed ID: 22745193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin D1 expression.
    Liu J; Uygur B; Zhang Z; Shao L; Romero D; Vary C; Ding Q; Wu WS
    Prostate; 2010 Dec; 70(16):1768-77. PubMed ID: 20564361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Female-specific rectal carcinogenesis in cyclin D1b transgenic mice.
    Kim CJ; Tambe Y; Mukaisho K; Sugihara H; Isono T; Sonoda H; Shimizu T; Kondoh G; Inoue H
    Carcinogenesis; 2014 Jan; 35(1):227-36. PubMed ID: 23975835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
    Kim CJ; Terado T; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
    Int J Oncol; 2018 Jan; 52(1):231-240. PubMed ID: 29115414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLUG-induced elevation of D1 cyclin in breast cancer cells through the inhibition of its ubiquitination.
    Mittal MK; Singh K; Misra S; Chaudhuri G
    J Biol Chem; 2011 Jan; 286(1):469-79. PubMed ID: 21044962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.
    Little GH; Baniwal SK; Adisetiyo H; Groshen S; Chimge NO; Kim SY; Khalid O; Hawes D; Jones JO; Pinski J; Schones DE; Frenkel B
    Cancer Res; 2014 May; 74(10):2857-68. PubMed ID: 24648349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.